19. INCOME TAXES
The components of income tax expense (benefit) for the years ended December 31 were as follows:
2013 | 2012 | 2011 | |||||||||||
(in millions) | |||||||||||||
Current tax expense (benefit) | |||||||||||||
U.S. | $ | (292) | $ | 674 | $ | 73 | |||||||
State and local | 16 | 27 | 2 | ||||||||||
Foreign | 310 | 387 | 372 | ||||||||||
Total | 34 | 1,088 | 447 | ||||||||||
Deferred tax expense (benefit) | |||||||||||||
U.S. | 44 | (437) | 771 | ||||||||||
State and local | 0 | (5) | 12 | ||||||||||
Foreign | (1,136) | (433) | 285 | ||||||||||
Total | (1,092) | (875) | 1,068 | ||||||||||
Total income tax expense (benefit) on continuing operations before equity in earnings of operating | |||||||||||||
joint ventures | (1,058) | 213 | 1,515 | ||||||||||
Income tax expense on equity in earnings of operating joint ventures | 19 | 19 | 79 | ||||||||||
Income tax expense on discontinued operations | 3 | 8 | 18 | ||||||||||
Income tax expense (benefit) reported in equity related to: | |||||||||||||
Other comprehensive income | (582) | 2,667 | 1,301 | ||||||||||
Stock-based compensation programs | (32) | (56) | (19) | ||||||||||
Total income taxes | $ | (1,650) | $ | 2,851 | $ | 2,894 |
The Company's actual income tax expense on continuing operations before equity in earnings of operating joint ventures for the years ended December 31 differs from the expected amount computed by applying the statutory federal income tax rate of 35% to income from continuing operations before income taxes and equity in earnings of operating joint ventures for the following reasons:
2013 | 2012 | 2011 | |||||||||||
(in millions) | |||||||||||||
Expected federal income tax expense (benefit) | $ | (589) | $ | 248 | $ | 1,737 | |||||||
Non-taxable investment income | (319) | (302) | (247) | ||||||||||
Low income housing and other tax credits | (105) | (78) | (80) | ||||||||||
Reversal of acquisition opening balance sheet deferred tax items | 55 | 384 | 221 | ||||||||||
Medicare Part D | (43) | (1) | (2) | ||||||||||
Minority interest | (37) | (17) | (11) | ||||||||||
Foreign taxes at other than U.S. rate | (36) | (51) | (37) | ||||||||||
State taxes | 10 | 15 | 0 | ||||||||||
Other | 6 | 15 | (66) | ||||||||||
Total income tax expense (benefit) on continuing operations before equity in earnings of | |||||||||||||
operating joint ventures | $ | (1,058) | $ | 213 | $ | 1,515 |
The dividends received deduction (“DRD”) reduces the amount of dividend income subject to U.S. tax and is the primary component of the non-taxable investment income shown in the table above, and, as such, is a significant component of the difference between the Company's effective tax rate and the federal statutory tax rate of 35%. The DRD for the current period was estimated using information from 2012 and current year results, and was adjusted to take into account the current year's equity market performance. The actual current year DRD can vary from the estimate based on factors such as, but not limited to, changes in the amount of dividends received that are eligible for the DRD, changes in the amount of distributions received from mutual fund investments, changes in the account balances of variable life and annuity contracts, and the Company's taxable income before the DRD.
In August 2007, the IRS released Revenue Ruling 2007-54, which included, among other items, guidance on the methodology to be followed in calculating the DRD related to variable life insurance and annuity contracts. In September 2007, the IRS released Revenue Ruling 2007-61. Revenue Ruling 2007-61 suspended Revenue Ruling 2007-54 and informed taxpayers that the U.S. Treasury Department and the IRS intend to address through new guidance the issues considered in Revenue Ruling 2007-54, including the methodology to be followed in determining the DRD related to variable life insurance and annuity contracts. In May 2010, the IRS issued an Industry Director Directive (“IDD”) confirming that the methodology for calculating the DRD set forth in Revenue Ruling 2007-54 should not be followed. The IDD also confirmed that the IRS guidance issued before Revenue Ruling 2007-54, which guidance the Company relied upon in calculating its DRD, should be used to determine the DRD. In February 2014, the IRS released Revenue Ruling 2014-7, which modified and superseded Revenue Ruling 2007-54, by removing the provisions of Revenue Ruling 2007-54 related to the methodology to be followed in calculating the DRD and obsoleting Revenue Ruling 2007-61. However, there remains the possibility that the IRS and the U.S. Treasury will address, through subsequent guidance, the issues related to the calculation of the DRD. For the last several years, the revenue proposals included in the Obama Administration's budgets included a proposal that would change the method used to determine the amount of the DRD. A change in the DRD, including the possible retroactive or prospective elimination of this deduction through guidance or legislation, could increase actual tax expense and reduce the Company's consolidated net income. These activities had no impact on the Company's 2011, 2012 or 2013 results.
The Medicare Part D subsidy provided by the government is not subject to tax. However, the amount a company can otherwise deduct for retiree health care expenses must be reduced by the amount of the Medicare Part D subsidy received and not taxed in that year, effectively making the subsidy taxable. During 2013, the Company transferred $340 million of assets within the qualified pension plan under Section 420 of the Internal Revenue Code from assets supporting pension benefits to assets supporting retiree medical and life benefits. As a result, the Company reduced the projected amount of retiree health care payments that would not be deductible related to future receipts by the Company of the Medicare Part D subsidy and recognized a $43 million tax benefit in "Income from continuing operations before equity in earnings of operating joint ventures."
Total income tax expense includes additional tax expense related to the realization of deferred tax assets recorded in the Statement of Financial Position as of the acquisition date for Prudential Gibraltar and the Star and Edison Businesses. As of December 31, 2013, additional U.S. GAAP tax expense related to the utilization of opening balance sheet deferred tax assets has been fully recognized between the Statement of Operations and Other Comprehensive Income as follows:
Prudential Gibraltar | Star and Edison Businesses | Total | ||||||||||
(in millions) | ||||||||||||
Opening balance sheet deferred tax assets after valuation allowance that will result | ||||||||||||
in additional tax expense | $ | 56 | $ | 678 | $ | 734 | ||||||
Additional tax expense (benefit) recognized in the Statement of Operations: | ||||||||||||
2009 | 13 | 0 | 13 | |||||||||
2010 | 6 | 0 | 6 | |||||||||
2011 | (29) | 252 | 223 | |||||||||
2012 | 51 | 333 | 384 | |||||||||
2013 | 15 | 40 | 55 | |||||||||
Subtotal | 56 | 625 | 681 | |||||||||
Additional tax expense recognized in Other Comprehensive Income | 0 | 53 | 53 | |||||||||
Unrecognized balance of additional tax expense | $ | 0 | $ | 0 | $ | 0 |
On January 1, 2012, the Star and Edison Businesses merged into Gibraltar Life. The majority of additional U.S. tax expense recognized in 2012 is a result of the merger. During the first quarter of 2013, the Company changed its repatriation assumption for Gibraltar Life and Prudential Gibraltar. As a result, the Company recorded an additional U.S. tax expense of $108 million in the first quarter of 2013. Future losses in pre-tax income of Gibraltar Life, such as that caused by the impact of foreign currency exchange rate movements on certain non-yen denominated assets and liabilities, may reduce the amount of additional tax expense recognized in the Consolidated Statements of Operations and increase the amount of additional tax expense recognized in Other Comprehensive Income.
Deferred tax assets and liabilities at December 31 resulted from the items listed in the following table:
2013 | 2012 | |||||||
(in millions) | ||||||||
Deferred tax assets | ||||||||
Insurance reserves | $ | 2,760 | $ | 3,952 | ||||
Policyholders' dividends | 1,797 | 2,433 | ||||||
Net operating and capital loss carryforwards | 358 | 866 | ||||||
Employee benefits | 477 | 718 | ||||||
Investments | 1,510 | 0 | ||||||
Other | 472 | 343 | ||||||
Deferred tax assets before valuation allowance | 7,374 | 8,312 | ||||||
Valuation allowance | (235) | (280) | ||||||
Deferred tax assets after valuation allowance | 7,139 | 8,032 | ||||||
Deferred tax liabilities | ||||||||
Net unrealized investment gains | 7,147 | 8,451 | ||||||
Deferred policy acquisition costs | 4,208 | 3,559 | ||||||
Investments | 0 | 1,753 | ||||||
Unremitted foreign earnings | 679 | 1,216 | ||||||
Value of business acquired | 1,204 | 1,029 | ||||||
Deferred tax liabilities | 13,238 | 16,008 | ||||||
Net deferred tax liability | $ | (6,099) | $ | (7,976) |
The application of U.S. GAAP requires the Company to evaluate the recoverability of deferred tax assets and establish a valuation allowance if necessary to reduce the deferred tax asset to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance the Company considers many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized.
A valuation allowance has been recorded related to tax benefits associated with state and local and foreign deferred tax assets. Adjustments to the valuation allowance are made to reflect changes in management's assessment of the amount of the deferred tax asset that is realizable and the amount of deferred tax asset actually realized during the year. The valuation allowance includes amounts recorded in connection with deferred tax assets at December 31 as follows:
2013 | 2012 | |||||||
(in millions) | ||||||||
Valuation allowance related to state and local deferred tax assets | $ | 208 | $ | 250 | ||||
Valuation allowance related to foreign operations deferred tax assets | $ | 27 | $ | 30 |
The following table sets forth the federal, state and foreign operating and capital loss carryforwards for tax purposes, at December 31:
2013 | 2012 | |||||||
(in millions) | ||||||||
Federal net operating and capital loss carryforwards | $ | 0 | $ | 274 | ||||
State net operating and capital loss carryforwards (1) | $ | 3,945 | $ | 4,574 | ||||
Foreign operating loss carryforwards (2) | $ | 505 | $ | 1,731 |
The Company provides for U.S. income taxes on unremitted foreign earnings of its operations in Japan, and certain operations in India, Germany, and Taiwan. In addition, beginning in 2012, the Company provides for U.S. income taxes on a portion of current year foreign earnings for its insurance operations in Korea. Unremitted foreign earnings from operations in other foreign jurisdictions are considered to be permanently reinvested. In 2011 the Company sold various foreign entities that were a part of the global commodities group and the relocation business. Consequently, their earnings were no longer considered permanently reinvested and the Company recognized an income tax expense of $6 million related to the sale of global commodities group in “Income from discontinued operations, net of taxes” and income tax benefit of $11 million related to the sale of the relocation business. Except for the change in repatriation assumption with respect to a portion of current year foreign earnings for insurance operations in Korea, the Company made no material changes with respect to its repatriation assumptions during 2012. During the first quarter of 2013, we determined that in addition to U.S. GAAP earnings, we would repatriate an additional amount from Gibraltar Life and Prudential Gibraltar, but that such additional amount would not exceed the deferred tax assets recorded in the Statement of Financial Position as of the acquisition date for Prudential Gibraltar and the Star and Edison Businesses. Consequently we recognized an additional U.S. tax expense of $108 million in “Income from continuing operations before equity in earnings of operating joint ventures” during 2013.
The following table sets forth the undistributed earnings of foreign subsidiaries, where the Company assumes permanent reinvestment of such and for which U.S. deferred taxes have not been provided, as of the periods indicated. Determining the tax liability that would arise if these earnings were remitted is not practicable.
At December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
(in millions) | |||||||||||||
Undistributed earnings of foreign subsidiaries (assuming permanent reinvestment) | $ | 1,973 | $ | 1,747 | $ | 2,145 |
The Company's income (loss) from continuing operations before income taxes and equity in earnings of operating joint ventures includes income from domestic operations of $1,274 million, $1,138 million and $1,919 million, and income (loss) from foreign operations of $(2,958) million, $(430) million and $3,045 million for the years ended December 31, 2013, 2012 and 2011, respectively.
The Company's liability for income taxes includes the liability for unrecognized tax benefits and interest that relate to tax years still subject to review by the Internal Revenue Service (“IRS”) or other taxing authorities. The completion of review or the expiration of the Federal statute of limitations for a given audit period could result in an adjustment to the liability for income taxes.
The Company's unrecognized tax benefits for the years ended December 31 are as follows:
2013 | 2012 | 2011 | |||||||||
(in millions) | |||||||||||
Balance at January 1, | $ | 19 | $ | 90 | $ | 552 | |||||
Increases in unrecognized tax benefits - prior years | 0 | 16 | 96 | ||||||||
(Decreases) in unrecognized tax benefits- prior years | (7) | (4) | (152) | ||||||||
Increases in unrecognized tax benefits - current year | 0 | 0 | 0 | ||||||||
(Decreases) in unrecognized tax benefits- current year | 0 | 0 | 0 | ||||||||
Settlements with taxing authorities | (1) | (83) | (406) | ||||||||
Balance at December 31, | $ | 11 | $ | 19 | $ | 90 | |||||
Unrecognized tax benefits that, if recognized, would favorably impact the | |||||||||||
effective rate | $ | 11 | $ | 19 | $ | 38 |
The Company does not anticipate any significant changes within the next 12 months to its total unrecognized tax benefits related to tax years for which the statute of limitations has not expired.
The Company classifies all interest and penalties related to tax uncertainties as income tax expense (benefit). The amounts recognized in the consolidated financial statements for tax-related interest and penalties for the years ended December 31 are as follows:
2013 | 2012 | 2011 | |||||||||||
(in millions) | |||||||||||||
Interest and penalties recognized in the consolidated statements of operations | $ | 1 | $ | 4 | $ | 13 | |||||||
2013 | 2012 | ||||||||||||
(in millions) | |||||||||||||
Interest and penalties recognized in liabilities in the consolidated statements of | |||||||||||||
financial position | $ | 6 | $ | 8 |
Listed below are the tax years that remain subject to examination by major tax jurisdiction, at December 31, 2013:
Major Tax Jurisdiction | Open Tax Years | ||
United States | 2004 - 2013 | ||
Japan | Fiscal years ended March 31, 2009 - 2013 | ||
Korea | Fiscal years ended March 31, 2009 - 2013 and the period ended December 31, 2013 |
During 2004 through 2006, the Company entered into two transactions that involved, among other things, the payment of foreign income taxes that were credited against the Company's U.S. tax liability. On May 23, 2011, the IRS issued notices of proposed adjustments disallowing the foreign tax credits claimed and related transaction expenses. The total amount of the proposed adjustments for the transactions was approximately $200 million of tax and penalties. During the fourth quarter of 2011, the Company reached agreement with the IRS on the resolution of the proposed foreign tax credits disallowance. The impact to the 2011 results attributable to the settlement was an increase to tax expense of approximately $93 million. The settlement of the foreign tax credit transactions for 2004 through 2006 marked the conclusion of the IRS audits for those years. As a result, all unrecognized tax positions plus interest relating to tax years prior to 2007 were recognized in 2011. As such, 2011 benefited from a reduction to the liability for unrecognized tax benefits of $70 million, including the impact from the foreign tax credit disallowance.
For tax years 2007 through 2013, the Company is participating in the IRS's Compliance Assurance Program (“CAP”). Under CAP, the IRS assigns an examination team to review completed transactions contemporaneously during these tax years in order to reach agreement with the Company on how they should be reported in the tax returns. If disagreements arise, accelerated resolutions programs are available to resolve the disagreements in a timely manner before the tax returns are filed. It is management's expectation this program will shorten the time period between the filing of the Company's federal income tax returns and the IRS's completion of its examination of the returns.
Certain of the Company's affiliates in Japan file a consolidated tax return, while others file separate tax returns. The Company's affiliates in Japan are subject to audits by the local taxing authority. The general statute of limitations is five years from when the return is filed. During 2011, the Tokyo Regional Taxation Bureau concluded a routine tax audit of the tax returns of Edison Life Insurance Company Ltd. for its tax years ended March 31, 2009 to March 31, 2010. During 2013 the Tokyo Regional Taxation Bureau conducted a routine tax audit of the tax returns of the Company's affiliates in Japan for their tax years ended March 31, 2009 to March 31, 2012. These activities had no material impact on the Company's 2011, 2012 or 2013 results.
The Company's affiliates in South Korea file separate tax returns and are subject to audits by the local taxing authority. The general statute of limitations is five years from when the return is filed.